The Workers’ Compensation Research Institute (WCRI) issued a FlashReport on Tuesday which attempts to show how a Texas-like closed formulary, such as the Work Loss Data Institute’s “Official Disability Guidelines” formulary, might affect the prevalence and costs of drugs prescribed to Louisiana state employees. Louisiana Comp Blog reached out to local stakeholders to get their take on whether or not Louisiana prescribers would respond to a formulary the way Texas has and the way WCRI ponders in the report.
HB 592, the bill which would have established the Work Loss Data Institute’s “Official Disability Guidelines” (ODG) Appendix A closed pharmacy formulary as the law of the land in Louisiana failed last week after members of the Senate Labor and Industrial Relations Committee ran out of time to hear the bill. Supporters and advocates of the measure, including the bill’s sponsor Rep. Talbot, say they’ll be back for more.
Although the workers’ comp closed pharmacy formulary bills were voted down at the last Workers’ Compensation Advisory Council meeting in late April and have not yet been scheduled to be heard in Committee, several bills aimed at curbing opioid use among Louisianans generally have moved quickly forward. Stick with Louisiana Comp Blog for full coverage of comp-related happenings until the Session ends on June 8th.